SteveSChungMD

PubMed

• Cognitive and psychiatric adverse events during adjunctive cenobamate treatment in phase 2 and phase 3 clinical studies.
  Ferrari, L., Stern, S., Rosenfeld, W., Krauss, G., Chung, S.> ;Epilepsy & Behavior. 2024 Feb 1
• 8 citations
  The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters.
  Steve Chung, Jurriaan M Peters, Kamil Detyniecki, William Tatum, Adrian L Rabinowicz, Enrique Carrazana> ;Epilepsy & Behavior Reports. 2023 Jan 1
• 12 citations
  A systematic review of seizure clusters: Prevalence, risk factors, burden of disease and treatment patterns.
  Steve Chung, Jerzy P. Szaflarski, Eun Jung Choi, Jessica Claire Wilson, Saifuddin Kharawala, Gavneet Kaur, Lawrence J. Hirsch> ;Epilepsy Research. 2021 Nov 1
• 15 citations
  Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open-label extension of a randomized clinical study.
  Jacqueline A. French, Steve Chung, Gregory L. Krauss, Sang Kun Lee, Maciej Maciejowski, William E. Rosenfeld, Michael R. Sperling, Marc Kamin> ;Epilepsia. 2021 Jul 13
• 15 citations
  Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal spray
  M. René Bouw, Steve Chung, Barry E. Gidal, Aliceson King, Jerry Tomasovic, James W. Wheless, Peter J. Van Ess> ;Epilepsy Research. 2021 Mar 1
• 17 citations
  Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients.
  Georgia Montouris, Sami Aboumatar, David E. Burdette, Sanjeev V. Kothare, Ruben Kuzniecky, William E. Rosenfeld, Steve Chung> ;Epilepsy & Behavior. 2020 Sep 1
• 94 citations
  Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures
  Steve Chung, Jacqueline A. French, Jacek Kowalski, Gregory L. Krauss, Sang Kun Lee, Maciej Maciejowski, William E. Rosenfeld, Michael R. Sperling, Sarah Mizne, Marc Kamin> ;Neurology. 2020 Jun 2
• 3 citations
  Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures.
  Steve Chung, Saurabh R. Sinha, Aashit Shah, John M. Stern, Hailong Cheng, JungAh Jung, Todd Grinnell, David Blum> ;Epilepsy Research. 2019 Mar 29
• 18 citations
  Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials.
  Jeremy D. Slater, Steve Chung, Lynn Huynh, Mei Sheng Duh, Brian Gorin, Carolyn McMicken, Adam Ziemann, Jouko Isojarvi> ;Epilepsy Research. 2018 Jul 1
• 9 citations
  Optimizing clobazam treatment in patients with Lennox-Gastaut syndrome.
  Jouko Isojarvi, Barry E. Gidal, Steve Chung, Robert T. Wechsler> ;Epilepsy & Behavior. 2018 Jan 1
• 27 citations
  Perampanel with concomitant levetiracetam and topiramate: Post hoc analysis of adverse events related to hostility and aggression
  Steve Chung, Betsy Williams, Cindy Dobrinsky, Anna Patten, Haichen Yang, Antonio Laurenza> ;Epilepsy & Behavior. 2017 Oct 1
• Erratum to “Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study” [Epilepsy Res. 131 (2017) 70–75]
  Ali A. Asadi-Pooya, Michael R. Sperling, Steve Chung, Pavel Klein, Anyzeila Diaz, Sami Elmoufti, Jimmy Schiemann, John Whitesides> ;Epilepsy Research. 2017 May 10
• 22 citations
  Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study
  Ali A. Asadi-Pooya, Michael R. Sperling, Steve Chung, Pavel Klein, Anyzeila Diaz, Sami Elmoufti, Jimmy Schiemann, John Whitesides> ;Epilepsy Research. 2017 Mar 1
• 6 citations
  Long-term safety and sustained efficacy of USL255 (topiramate extended-release capsules) in patients with refractory partial-onset seizures
  Steve Chung, R. Edward Hogan, Ilan Blatt, P Balduin Lawson, Huy Nguyen, Annie Clark, Bob Anders, Mark Halvorsen> ;Epilepsy & Behavior. 2016 Jun 1
• 16 citations
  Clobazam and clonazepam use in epilepsy: Results from a UK database incident user cohort study.
  Martin J. Brodie, Steve Chung, Alan G Wade, Celine Quelen, Alice Guiraud-Diawara, Clément François, Patrice Verpillat, Vivienne Shen, Jouko Isojarvi> ;Epilepsy Research. 2016 Jul 1
• 3 citations
  Levetiracetam extended release for the treatment of patients with partial-onset seizures: A long-term, open-label follow-up study
  Steve Chung, Hugo Ceja, Jacek Gawłowicz, Cindy McShea, Jimmy Schiemann, Sarah Lu> ;Epilepsy Research. 2016 Feb 1
• 13 citations
  Challenges in identifying Lennox-Gastaut syndrome in adults: A case series illustrating its changing nature
  Jesus Eric Piña-Garza, Steve Chung, Georgia Montouris, Rodney A. Radtke, Trevor Resnick, Robert T. Wechsler> ;Epilepsy & Behavior Case Reports. 2016 Jan 1
• 14 citations
  Clobazam is equally safe and efficacious for seizures associated with Lennox-Gastaut syndrome across different age groups: Post hoc analyses of short- and long-term cl...
  Yu-Tze Ng, Joan A. Conry, Wendy G. Mitchell, Jeffrey Buchhalter, Jouko Isojarvi, Deborah Lee, Rebecca Drummond, Steve Chung> ;Epilepsy & Behavior. 2015 May 1
• 11 citations
  A review of the efficacy and safety of extended-release topiramate in the adjunctive treatment for refractory partial-onset seizures
  Steve Chung> ;Therapeutic Advances in Neurological Disorders. 2015 Mar 29
• 443 citations
  Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy
  , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Neurology. 2015 Mar 10
• 2 citations
  Cross Section of Stat (Emergent) EEG Use. Who Orders Them? What Do We Find? What Indications Best Predict Finding Seizures?
  Mohamed S. Teleb, Susan W. Lee, Amy Z. Crepeau, Jason Chang, Tzu Ching Wu, Kristina Chappie, Steve Chung, Rama Maganti> ;The Neurodiagnostic Journal. 2015 Jan 30
• 6 citations
  Clinical considerations in transitioning patients with epilepsy from clonazepam to clobazam: a case series
  Raman Sankar, Steve Chung, Michael Scott Perry, Ruben Kuzniecky, Saurabh R. Sinha> ;Journal of Medical Case Reports. 2014 Dec 16
• 7 citations
  Efficacy of once-daily extended-release topiramate (USL255): A subgroup analysis based on the level of treatment resistance
  R. Edward Hogan, Ilan Blatt, Balduin Lawson, Venkatesh Nagaraddi, Toufic Fakhoury, Bob Anders, Annie Clark, Dawn Laine, Mark Halvorsen, Steve Chung> ;Epilepsy & Behavior. 2014 Dec 1
• 3 citations
  USL255 extended-release topiramate for the treatment of epilepsy.
  Steve Chung> ;Expert Review of Neurotherapeutics. 2014 Sep 23
• 27 citations
  Once-daily USL255 as adjunctive treatment of partial-onset seizures: randomized phase III study.
  Steve Chung, Toufic Fakhoury, R. Edward Hogan, Venkatesh Nagaraddi, Ilan Blatt, Balduin Lawson, Stephan Arnold, Bob Anders, Annie Clark, Dawn Laine, R Shawn Meadows, M...> ;Epilepsia. 2014 Jul 1
• Join now to see all

Journal Articles

• Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study  
  Asadi-Pooya A., Sperling M., Chung S.S., Klein P., Diaz A., Schiemann J., Whitesides J., Epilepsy Research, 1/1/2017
• Long-Term Safety and Sustained Efficacy of USL255 (Topiramate Extended-Release Capsules) in Patients with Refractory Partial-Onset Seizures  
  Chung S.S., Hogan R., Blatt I., Lawson B., Nguyen H., Clark A., Anders B., Halvorsen M., Epilepsy and Behav, 1/1/2016
• New Treatment for Epilepsy and Case Discussions: Epilepsy Case Files  
  Chung S.S., Epivoice, 1/1/2016
• Use of Clobazam and Clonazepam in adults and children with epilepsy: Long-term results from a UK primary care database  
  Brodie M., Chung S.S., Wade A., Quelen C., Guiraud-Diawara A., Francois C., Verpillat P., Shen V. Isojarvi J., Epilepsy Research, 1/1/2016
• Levetiracetam extended release for the treatment of patients with partial-onset seizures: A long-term, open-label follow-up study  
  Chung S.S., Ceja H., Gawlowicz J., McShea C., Schiemann J., Lu S., Epilepsy Research, 1/1/2016
• Challenges in identifying Lennox-Gastaut syndrome in adults: A case series illustrating its changing nature  
  Pina-Garza, J.E., Chung S.S., Montouris G., Radtke R. Resnick T., Wechsler R., Epilepsy Behav Case Rep, 1/1/2016
• Long-term efficacy and safety of thalamic stimulation for drug resistance partial epilepsy  
  Salanova V., Witt T., Worth R., Henry T., Gross R., Nazzaro J., Labar D., Sperling M., Sharan A., Sandok E., Handforth C., Stern J., Chung S.S., Henderson J., French J..., Neurology, 1/10/2015
• Long-term efficacy and safety of adjunctive extended-release oxcarbazepine (Oxtellar XR) in adults with partial-onset seizures  
  Chung S.S., Johnson J.K., Brittain S.T., Baroldi P., Acta Neurol Scand, 1/1/2015
• Clobazam is equally safe and efficacious for seizures associated with Lennon-Gastaut syndrome across different age groups: Post hoc analyses of short- and long-term cl...  
  Ng Y., Conry J., Mitchell W., Buchhalter J., Isojarvi J., Lee D., Drummond R., Chung S.S., Epilepsy and Behav, 1/1/2015
• A review of the efficacy and safety of topiramate extended-release in the adjunctive treatment for refractory partial-onset seizures  
  Chung S.S., Ther Adv Neurol Dis, 1/1/2015
• Efficacy of once-daily extended release topiramate (USL255): a subgroup analysis based on level of treatment resistance Corresponding  
  Hogan R., Ian Blatt I., Lawson B., Nagaraddi V., Fakhoury T., Anders B., Clark A., Laine D., Halvorsen M., Chung S.S., Epilepsy Behav, 1/21/2014
• Clinical Considerations in Transitioning Patients with Epilepsy from Clonazepam to Clobazam: A Case Series  
  Sankar R.,Chung S.S., Perry S., Kuzniecky R., Sinha S., J Med Case Rep, 1/1/2014
• New and emerging treatments for epilepsy: Review of clinical studies of lacosamide, ezogabine, perampanel, and eslicarbazepine acetate  
  Chung S.S., Clin Investig, 1/1/2014
• SP615 Study Investigators Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open label extension trial of up to 8 ...  
  Rosenfield W, Fountain NB, Kaubrys G, Ben-Menachem E, McShea C, Isojarvi J, Doty P,, Epilepsy Behav, 1/1/2014
• PROSPER Investigators Study Group Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR) as adjunctive therapy in patients with refractory partial-onset s...  
  French JA, Baroldi P., Brittain ST, Johnson JK,, Acta Neurol Scand, 1/1/2014
• Once-daily USL255 as adjunctive treatment of partial onset seizures: Randomized phase III study  
  ChungS.S., FakhouryT.A., Hogan R., NagaraddiV., Blatt I., LawsonB., Arnold S., Anders B.,Clark A., Laine D., Meadows R., Halvorsen M., Epilepsia, 1/1/2014
• Characteristics of falls in the epilepsy monitoring unit: A retrospective study  
  Pati S, Kumaraswamy VM, Deep A, Chung S.S., Plueger M, Kiyota G, Treiman DM, Epilepsy Behav, 1/1/2013
• Epilepsy, Antiseizure Therapy and Sleep Cycle Parameters  
  Shvartz V., Chung S.S.,, Epilepsy Research and Treatment, 1/1/2013
• Perampanel: Novel Antiseizure Medication for Partial-onset Seizures  
  Shvartz V., Chung S.S.,, Expert Rev Neurother, 1/1/2013
• Managing common complex symptomatic epilepsies: tumors and trauma: american epilepsy society - 2012 annual course summary  
  Burneo J.G, Sirven J.I, Kiesel L.W, Vecht CJ, Jehi L, Chung S.S., Uhm J, Politsky JM, Chang EF, Husain AM, Tatum WO, Meador KJ, Noe K, Hesdorffer DC, Herman ST, Wiebe ..., Epilepsy Curr, 1/1/2013
• Cross section of stat (emergent) EEG use Who orders them? What do we find? What indications best predict finding seizures?  
  Teleb M., Lee S., Crepeau A., Chang J., Wu T.C., Chapple K., Chung S.S.,Maganti R., The Neurodiagnostic journal, 1/1/2012
• Fulminant pseudotumor cerebri presenting with atypical ataxia and hyperreflexia  
  Teleb M., Parikh G., Rekate H., Chung S.S., J Neurointerv Surg, 1/1/2012
• Levetiracetam extended-release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomized, multicentre, historical...  
  Chung S.S., Ceja H.,, Epilepsy Research, 1/1/2012
• Long-Term Safety and Efficacy in Patients with Uncontrolled Partial-Onset Seizures Treated With Adjunctive Lacosamide: Results from a Phase III Open-Label Extension Trial  
  Husain A., Chung S.S., Faught E., Isojarvi J, McShea C, Doty P., Epilepsia, 1/1/2012
• Early surgery is effective in drug resistant temporal lobe epilepsy: Results of a randomized, controlled trial  
  Engel J, McDermott M, Wiebe S, Langfitt J, Stern J., ERSET Study Group, et al, JAMA, 1/1/2012
• Join now to see all

Books/Book Chapters

• Side Effects of Drugs Annual (SEDA35) Volume 35 
  Chapter: Antiepileptic drugs 
  Chung S.S., Schusse C.Editors: Jeffery Aronson.2013
• Atlas of Video-EEG Monitoring 
  Chapter: Chapter-Secondarily Generalized Seizures 
  Chung S.S., Horne K.Editors: John Stern and Joseph Sirven.2011
• Atlas of Epilepsies 
  Chapter: Antiepileptic Drugs-Newest AEDs: Brivaracetam, Carisbamate, Eslicarbazepine, and Retigabin 
  Johannessen C., Johannessen S., Chung S.S.Editors: Thomas Panayiotopoulos.SpringerEdition 1st,2010
• Atlas of Epilepsies 
  Chapter: Ethosuzimide 
  Chansakul C., Chung S.S.Editors: Thomas Panayiotopoulos.SpringerEdition 1st,2010
• Atlas of Epilepsies 
  Chapter: New antiepileptic Drug - Rufinamide 
  Lee S., Chung S.S.Editors: Thomas Panayiotopoulos.SpringerEdition 1st,2010
• Atlas of Epilepsies 
  Chapter: Approach of the FDA re Anti-epileptic Medications 
  Pati S., Chung S.S.Editors: Thomas Panayiotopoulos.SpringerEdition 1st,2010
• Continuum epilepsy Issue 
  Chapter: How to Diagnose Epilepsy and Differential Diagnosis of Seizures 
  Drazkowski J. and Chung S.S.Editors: Joseph Sirven.2010
• Join now to see all

Abstracts/Posters

• Efficacy and Safety of USL255, Qudexy® XR (Topiramate) Extended-Release Capsules, and Second-Generation AEDs
  Steve Chung, R E. Hogan, Ilan Blatt,Baldwin Lawson, Mary Holmay, Mark Halvorsen, AAN Meeting, Boston, MA, 1/1/2017
• Long-term safety and Efficacy outcomes following conversion to eslicarbamzepine acetate (ESL) monotherapy in patients with partial-onset seizures: A post-hoc subgroup...
  Steve Chung, Sauabh Sinha, Ashit Shah, John Stern, Hailong Cheng. Todd Grinnell, David Blum, AAN Meeting, Boston, MA, 1/1/2017
• Efficacy of Brivaracetam as adjunctive therapy in partial onset seizures among patients with prior levetiracetam, carbamazepine, lamotrigine, or topiramate exposure
  Steve Chung,Pavel Klein,Michael Sperling,Anyzeila Diaz,Sami Elmoufti,Jimmy Schiemann,John Whitesides, AES Meeting – scientific session, Houston, TX, 1/1/2016
• Efficacy and Safety of USL255, Qudexy® XR (Topiramate) Extended-Release Capsules, and Second-Generation AEDs
  Steve Chung, R E. Hogan, Mary Holmay, Vincent Yu, Huy Nguyen, Ilan Blatt, Mark Halvorsen, AES Meeting, Houston, TX, 1/1/2016
• Efficacy of eslicarbamzepine acetate in patients with refractory partial-onset seizures treated with or without concomitant carbamazepine: a pooled analysis of three p...
  Steve Chung, Gregory Krauss, Michael Sperling, Eugene Trinka, Mar Carreno, David Blum, Patricio Soares-Silva, Rul Sousa, Todd Grinell, Hailong Cheng, AES Meeting, Houston, TX, 1/1/2016
• Efficacy of Brivaracetam as adjunctive therapy in partial onset seizures among patients with prior levetiracetam, carbamazepine, lamotrigine, or topiramate exposure
  Steve Chung,Pavel Klein,Michael Sperling,Anyzeila Diaz,Sami Elmoufti,Jimmy Schiemann,John Whitesides, AAN Meeting, Vancouver, BC, 1/1/2016
• Optimizing Clobazam treatment in patients with Lennox-Gastaut syndrome
  Robert T. Wechsler,Barry E. Gidal,Steve Chung,Guangbin Peng,Jouko Isojarvi, AAN Meeting, Vancouver, BC, 1/1/2016
• Development of Unique Dosage Form and Differentiating Features of USL255, Qudexy XR
  Steve Chung, R E. Hogan, Mary Holmay, Vincent Yu, Huy Nguyen, Ilan Blatt, Mark Halvorsen, AAN Meeting, Vancouver, BC, 1/1/2016
• Long-Term Efficacy of USL255 (Qudexy® XR; Topiramate Extended-Release Capsules) by Refractory Status and Age: PREVAIL OLE
  Robert Hogan, Ilan Blatt, Mary Holmay, Huy Nguyen, Vincent Yu, Mark Halvorsen, Steve Chung, AAN Meeting, Vancouver, BC, 1/1/2016
• An indirect comparison of selected adjunctive treatments for refractory partial onset seizures: Does evidence matter?
  J. D. Slater, Steve Chung, L. Huynh, M. Sheng Duh, B. Gorin, C. McMicken, A. Ziemann, J. Isojarvi, AAN Meeting, Vancouver, BC, 1/1/2016
• Neurocognitive Adverse Event Profile of USL255 (Qudexy® XR; Topiramate Extended-Release Capsules): Phase 3 PREVAIL and PREVAIL OLE Studies
  Ilan Blatt, Steve Chung, Balduin Lawson, Huy Nguyen, Mary Holmay, Vincent Yu, Mark Halvorsen, R E. Hogan, AAN Meeting, Vancouver, BC, 1/1/2016
• Jacquelyn Bainbridge, Pei shieen Wong, Mark Spitz, Lauren Frey, Archana Shrestha, Laura Strom, Selim Benbadis, Joseph Sirven, Steve S. Chung, AES Meeting, Philadelphia, PA, 1/1/2015
• Evaluation of Clobazam Conversion Therapy Replacing Clonazepam in Patients with Medically Refractory Epilepsy - A 12 Month Follow-up
  Stephanie Marsh, Steve Chung, Abstract and scientific exhibit, AES Meeting, Philadelphia, PA, 1/1/2015
• Challenges in Identifying Lennox–Gastaut Syndrome: A Case Series Illustrating its Changing Nature
  J. Pina-Garza, Steve Chung, G. Montouris, R. Radtke, T. Resnick, R. Wechsler, AES Meeting, Philadelphia, PA, 1/1/2015
• An indirect comparison of selected adjunctive treatments for refractory partial onset seizures: Does evidence matter?
  J. D. Slater, Steve Chung, L. Huynh, M. Sheng Duh, B. Gorin, C. McMicken, A. Ziemann, J. Isojarvi, AES Meeting, Philadelphia, PA, 1/1/2015
• Efficacy of Eslicarbazepine acetate in patients with refractory partial-onset seizures treated with or without concomitant carbamazepine: a pooled analysis of three Ph...
  Steve Chung, Gregory Krauss, michael Sperling, Eugene Trinka, Mar Carreno, David Blum, Patricio Soares-da-Silva, Rui Sousa, Todd Grinell, Hailong Cheng, Scientific Exhibit, AES Meeting, Philadelphia, PA, 1/1/2015
• Optimizing Clobazam treatment in patients with Lennox-Gastaut syndrome
  Jouko Isojarvi, Barry Gidel, Steve Chung, Robert Wechsler, Guangbin Peng, Scientific Exhibit, AES Meeting, 1/1/2015
• Long-Term Efficacy of USL255 (Qudexy® XR; Topiramate Extended-Release Capsules) by Refractory Status and Age: PREVAIL OLE
  Robert Hogan, Ilan Blatt, Mary Holmay, Huy Nguyen, Vincent Yu, Mark Halvorsen, Steve Chung, AES Meeting, Philadelphia, PA, 1/1/2015
• Neurocognitive Adverse Event Profile of USL255 (Qudexy® XR; Topiramate Extended-Release Capsules): Phase 3 PREVAIL and PREVAIL OLE Studies
  Ilan Blatt, Steve Chung, Balduin Lawson, Huy Nguyen, Mary Holmay, Vincent Yu, Mark Halvorsen, R E. Hogan, AES Meeting, Philadelphia, PA, 1/1/2015
• Development of Unique Dosage Form and Differentiating Features of USL255, Qudexy® XR (Topiramate) Extended-Release Capsules
  Steve Chung, R E. Hogan, Mary Holmay, Vincent Yu, Huy Nguyen, Ilan Blatt, Mark Halvorsen, AES Meeting, Philadelphia, PA, 1/1/2015
• Clobazam vs. Clonazepam for Adults with Epilepsy: Long-Term Results from a UK Primary Care DatabaseClobazam vs. Clonazepam for Adults with Epilepsy: Long-Term Results ...
  Martin Brodie,Steve Chung,Alan Wade,Celine Quelen,Alice Guiraud-Diawara,Clement Francois,Patrice Verpillat,Vivienne Shen,Daniel Jones,Jouko Isojarvi, AAN Meeting, Washington, DC, 1/1/2015
• Retention Rate and Efficacy of Clobazem in comparison to other Newer Anticonvulsants in Patients with Epilepsy
  Steve Chung, Thandar Aung, AAN Meeting, Washington, DC, 1/1/2015
• Long-Term Utilization Differences Between Children Treated with Clobazam vs. Clonazepam for Epilepsy in the UK
  Steve Chung,Martin Brodie,Alan Wade,Celine Quelen,Alice Guiraud-Diawara,Clement Francois,Patrice Verpillat,Vivienne Shen,Daniel Jones,Jouko Isojarvi, AAN Meeting, Washington, DC, 1/1/2015
• Long-Term Efficacy, Safety, and Impact on Quality of Life of USL255, Qudexy™ XR (Topiramate) Extended-Release Capsules: PREVAIL OLE
  Robert Hogan,Ian Blatt,Annie Clark,Bob Anders,Mark Halvorsen,Steve Chung, AAN Meeting, Washington, DC, 1/1/2015
• Conversion to Lacosamide Monotherapy: Post-hoc Analysis on Responder and Seizure Freedom Rates by Patients’ Baseline Characteristics
  Philippe Ryvlin,Michael Sperling,Steve Chung,John Stern,Robert Wechsler,Svetlana Dimova,Marc De Backer,Tyler Story,Melissa Brock,Cindy McShea,Paulette Williams,Konrad ..., AAN Meeting, Washington, DC, 1/1/2015
• Join now to see all

Lectures

• Brain Tumor-Related Epilepsy: Pathophysiology and Treatment 
  Neuroscience Grand Rounds, Creighton University, Omaha - 1/19/2017
• New Advancement in Treatment of Epilepsy 
  DDNA Annual Education Conference, Dallas, TX - 1/9/2017
• Treatment of Seizure Disorder and Concomitant Illness 
  North Texas Nurse Practitioner Annual Meeting, Dallas, TX - 1/8/2017
• Evidence-Based AED Combination Therapy 
  Asian Epilepsy Academy ILAE, Taipei, Taiwan - 1/1/2017
• Overview of Newer AEDs 
  Asian Epilepsy Academy ILAE, Taipei, Taiwan - 1/1/2017
• LCM as a Treatment Option for Epilepsy Patients 
  Asian Epilepsy Academy - Satellite Symposium Taipei, Taiwan - 1/1/2017
• How to Treat Epilepsy Patients After Failing the 1st AED 
  Kaohsiung Medical Center Grand Rounds, Kaohsiung, Taiwan - 1/1/2017
• Approach of Seizure Disorder and Selecting Treatment 
  Gerontological Advanced Practice Nurses Association Annual Meeting, Phoenix, AZ - 1/23/2016
• What is the cause for seizures in brain tumor patients 
  Neurology Grand Round - 1/19/2016
• EEG Interpretation through Life Cycle 
  National Resident Scholarship Program, Phoenix, AZ - 1/16/2016
• Foundation of EEG Interpretation and Instrumentation 
  National Resident Scholarship Program - 1/16/2016
• Treatment of Acute Seizures and Status Epilepticus 
  National Resident Scholarship Program - 1/16/2016
• Monotherapy Trials of Epilepsy Medications Based on Historical Control 
  Philippines League Against Epilepsy Meeting, Manila, Philippines - 1/1/2016
• Visiting Professor and Case Discussions 
  University of Santa Thomas, Manila, Philippines - 1/1/2016
• New Pharmacological and Surgical Treatment for Epilepsy 
  Neurology Grandrounds Siriraj Hospital, Bangkok, Thailand - 1/1/2016
• Emerging Treatment for Epilepsy 
  1st Thailand Epilepsy Symposium Bangkok, Thailand - 1/1/2016
• Role of Lacosamide New Treatment in Epilepsy 
  1st Thailand Epilepsy Symposium Bangkok, Thailand - 1/1/2016
• Behavioral and Psychological Issues in Epilepsy 
  Brain Conference 2016, Chinese University of Hong Kong, Hong Kong - 1/1/2016
• Monotherapy vs. Polytherapy in Epilepsy Treatment 
  Hong Kong Epilepsy Society Meeting, Hong Kong - 1/1/2016
• Instrumentation of EEG and Clinical Interpretation 
  Brain Conference 2016, Chinese University of Hong Kong, Hong Kong - 1/1/2016
• How to Choose Medications for Your Patients with Epilepsy 
  CME Symposium in Epilepsy, Los Angeles, CA - 1/28/2015
• Advanced Clinical EEG: Pediatric and Adult EEG 
  National Resident Scholarship Program - 1/26/2015
• Basic Principles of EEG Generation and Interpretation 
  National Resident Scholarship Program - 1/25/2015
• AED Pharmacotherapy: Novel Agents and Formulations 
  National Resident Scholarship Program - 1/25/2015
• Minimally Invasive Surgery for Seizure: The BNI Approach 
  Neuroscience Grand Rounds, Creighton University, Omaha - 1/20/2015
• Join now to see all

Other

• Practical Consideration for the Use of Modern AEDs 
  Chung S.S., Medscape CME Program - Televised
  1/29/2016
• To Titrate or Not: Optimizing Treatment with AEDs 
  Chung S.S., Medscape CME Program - Televised
  1/1/2015
• eMedicine.com, Neurology chapter (editor) 
  Chung S.S. Kirshner, H.S.
  eMedicine.com - 1/1/2000